Year: 2024

Otsuka_Logo_Color_RGB

Otsuka Announces Phase 3 Topline Results of AVP-786 in the Treatment of Agitation Associated With Dementia Due to Alzheimer’s Disease

PRINCETON, N.J. & TOKYO--(BUSINESS WIRE)--Otsuka Pharmaceutical Development & Commercialization, Inc., (OPDC) and our parent company Otsuka Pharmaceutical, Co. Ltd. (Otsuka)...

logo-66

Desalination Industry Innovations: New Research Reveals Cutting-Edge Technologies Redefining Water Security – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Radical Innovation Transforming the Desalination Industry" report has been added to ResearchAndMarkets.com's offering. The rising population is driving...